Certech has expanded its additive manufacturing capabilities with the acquisition of three 3D printing instruments aimed at advancing personalized medicine and enhancing the integration of 3D technologies in healthcare:
- A compact filament extruder allowing to process limited quantities of material, making it particularly suited for R&D and pharmaceutical formulation screening.
- A 3D printer equipped with five extrusion printing heads, offering the flexibility to create complex pharmaceutical dosage forms, such as Polypills, combining multiple active ingredients into a single, patient-specific unit.
- A dual extruder capable of processing both pellets and filaments, allowing the direct printing of challenging materials that are difficult to convert into filament.
These instruments are compatible with most thermoplastic polymers and will allow to develop custom polymer formulations incorporating active pharmaceutical ingredients and excipients, tailored for additive manufacturing and the implementation of personalized medical solutions. Certech filament extrusion pilot line is also available for larger volume developments.
Certech thus reaffirms its commitment to supporting innovation and the transition to more personalized and accessible medicine.
